开云app官网登录入口网页版-官方正版

#Cas9#

122篇内容 | 2503人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1365085, encodeId=d1f1136508546, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=当心！Nat Commun发文：CRISPR/Cas9基因编辑可能导致细胞毒性和基因组不稳定性, objectType=article, longId=737096, objectId=ae3de37096f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae3de37096f2, replyNumber=0, likeNumber=94, createdTime=2022-08-28, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae3de37096f2, moduleTitle=当心！Nat Commun发文：CRISPR/Cas9基因编辑可能导致细胞毒性和基因组不稳定性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ae3de37096f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365084, encodeId=9cbd136508433, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=JACS：中科大梁好均团队开发基于CRISPR-dCas9的可编程转录调节器, objectType=article, longId=731568, objectId=2b32e3156877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b32e3156877, replyNumber=0, likeNumber=113, createdTime=2022-07-09, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b32e3156877, moduleTitle=JACS：中科大梁好均团队开发基于CRISPR-dCas9的可编程转录调节器, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2b32e3156877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365083, encodeId=e96a1365083be, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=现货型CAR-T疗法的危机：Cas9基因编辑后，T细胞繁现染色体异常, objectType=article, longId=731446, objectId=0e9de3144639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e9de3144639, replyNumber=0, likeNumber=75, createdTime=2022-07-08, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e9de3144639, moduleTitle=现货型CAR-T疗法的危机：Cas9基因编辑后，T细胞繁现染色体异常, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=0e9de3144639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365082, encodeId=eaa7136508206, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=Nature子刊：北京大学胡家志团队开发出更为安全的Cas9变体Cas9TX, objectType=article, longId=300614, objectId=793930061422, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=793930061422, replyNumber=0, likeNumber=92, createdTime=2022-03-14, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=793930061422, moduleTitle=Nature子刊：北京大学胡家志团队开发出更为安全的Cas9变体Cas9TX, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=793930061422)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365081, encodeId=256d136508189, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=Cell Research：舒易来等开发CRISPR/Cas9-HMEJ基因修复体系治疗隐性遗传性聋, objectType=article, longId=299835, objectId=824a299835f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=824a299835f0, replyNumber=0, likeNumber=81, createdTime=2022-03-02, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=824a299835f0, moduleTitle=Cell Research：舒易来等开发CRISPR/Cas9-HMEJ基因修复体系治疗隐性遗传性聋, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=824a299835f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365080, encodeId=08e21365080c8, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=NEJM：采用CRISPR-Cas9进行在体基因编辑治疗转甲状腺素蛋白淀粉样变性, objectType=article, longId=215474, objectId=cc6f2154e469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc6f2154e469, replyNumber=0, likeNumber=96, createdTime=2021-08-10, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc6f2154e469, moduleTitle=NEJM：采用CRISPR-Cas9进行在体基因编辑治疗转甲状腺素蛋白淀粉样变性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=cc6f2154e469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365079, encodeId=985813650e9a4, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=NEJM：CRISPR-Cas9体内基因编辑治疗转甲状腺素蛋白淀粉样变性, objectType=article, longId=215363, objectId=58cb215363aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58cb215363aa, replyNumber=0, likeNumber=98, createdTime=2021-08-07, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58cb215363aa, moduleTitle=NEJM：CRISPR-Cas9体内基因编辑治疗转甲状腺素蛋白淀粉样变性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=58cb215363aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365078, encodeId=25f313650e8d6, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=N Engl J Med ：首次！CRISPR-Cas9技术可在人体实验中有效治疗镰状细胞贫血和β-地中海贫血, objectType=article, longId=205010, objectId=cced205010d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cced205010d4, replyNumber=0, likeNumber=52, createdTime=2021-01-01, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cced205010d4, moduleTitle=N Engl J Med ：首次！CRISPR-Cas9技术可在人体实验中有效治疗镰状细胞贫血和β-地中海贫血, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=cced205010d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365077, encodeId=e76013650e708, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=CRISPR/ Cas9基因编辑疗法全新临床进展, objectType=article, longId=204286, objectId=f54e20428668, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f54e20428668, replyNumber=0, likeNumber=66, createdTime=2020-12-09, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f54e20428668, moduleTitle=CRISPR/ Cas9基因编辑疗法全新临床进展, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f54e20428668)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365076, encodeId=ba1d13650e6f2, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=CELL：CRISPR/Cas9编辑人类胚胎可能导致大片段突变, objectType=article, longId=202693, objectId=c7bd20269374, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7bd20269374, replyNumber=0, likeNumber=78, createdTime=2020-11-01, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7bd20269374, moduleTitle=CELL：CRISPR/Cas9编辑人类胚胎可能导致大片段突变, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c7bd20269374)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365075, encodeId=721a13650e54a, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=Br J Cancer：CRISPR/Cas9全基因组功能丧失筛选技术鉴定法尼基蛋白转移酶参与肾细胞癌的舒尼替尼耐药性, objectType=article, longId=201704, objectId=45e8201e0416, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45e8201e0416, replyNumber=0, likeNumber=84, createdTime=2020-10-07, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45e8201e0416, moduleTitle=Br J Cancer：CRISPR/Cas9全基因组功能丧失筛选技术鉴定法尼基蛋白转移酶参与肾细胞癌的舒尼替尼耐药性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=45e8201e0416)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365074, encodeId=4cdb13650e438, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=Science：科学家发现新型基因编辑工具，体积是CRISPR-Cas9的一半, objectType=article, longId=197930, objectId=d15219e930c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d15219e930c8, replyNumber=0, likeNumber=65, createdTime=2020-07-24, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d15219e930c8, moduleTitle=Science：科学家发现新型基因编辑工具，体积是CRISPR-Cas9的一半, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d15219e930c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365073, encodeId=2df513650e30e, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=CRISPR / Cas9疗法OTQ923治疗镰状细胞疾病：FDA已批准进行临床试验, objectType=article, longId=191237, objectId=098119123ef1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=098119123ef1, replyNumber=0, likeNumber=66, createdTime=2020-04-03, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=098119123ef1, moduleTitle=CRISPR / Cas9疗法OTQ923治疗镰状细胞疾病：FDA已批准进行临床试验, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=098119123ef1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365072, encodeId=273413650e238, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=Circulation：CRISPR/Cas9基因编辑或可用于治疗LDLR突变型家族性高胆固醇血症, objectType=article, longId=185698, objectId=7e00185698b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e00185698b8, replyNumber=0, likeNumber=79, createdTime=2020-01-06, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e00185698b8, moduleTitle=Circulation：CRISPR/Cas9基因编辑或可用于治疗LDLR突变型家族性高胆固醇血症, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=7e00185698b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365071, encodeId=ba3b13650e149, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=PNAS：探究“致命”肺癌，科学家发现CRISPR-Cas9系统新应用, objectType=article, longId=185466, objectId=155d185466bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=155d185466bf, replyNumber=0, likeNumber=81, createdTime=2020-01-01, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=155d185466bf, moduleTitle=PNAS：探究“致命”肺癌，科学家发现CRISPR-Cas9系统新应用, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=155d185466bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365070, encodeId=73a613650e0c5, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=Nat Commun：研究发现CRISPR-Cas9基因编辑系统在灵长类中不会导致明显的脱靶效应, objectType=article, longId=184737, objectId=5df1184e3771, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5df1184e3771, replyNumber=0, likeNumber=74, createdTime=2019-12-15, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5df1184e3771, moduleTitle=Nat Commun：研究发现CRISPR-Cas9基因编辑系统在灵长类中不会导致明显的脱靶效应, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5df1184e3771)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365069, encodeId=58c813650699a, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=Vertex揭示了在首批接受CRISPR/Cas9基因编辑疗法患者中激动人心的数据, objectType=article, longId=183489, objectId=74b918348978, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74b918348978, replyNumber=0, likeNumber=81, createdTime=2019-11-25, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74b918348978, moduleTitle=Vertex揭示了在首批接受CRISPR/Cas9基因编辑疗法患者中激动人心的数据, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=74b918348978)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365068, encodeId=df4b136506884, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=Nat Biotech：媲美CRISPR-Cas9, 新CRISPR 工具探知90%的基因编辑领域, objectType=article, longId=180224, objectId=b4a818022443, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4a818022443, replyNumber=0, likeNumber=63, createdTime=2019-09-30, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4a818022443, moduleTitle=Nat Biotech：媲美CRISPR-Cas9, 新CRISPR 工具探知90%的基因编辑领域, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b4a818022443)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365067, encodeId=8888136506e5e, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=SCI TRANS MED：CRISPR-Cas9编辑造血干细胞，助力治疗相关移植, objectType=article, longId=176793, objectId=62aa1e679336, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62aa1e679336, replyNumber=0, likeNumber=58, createdTime=2019-08-05, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62aa1e679336, moduleTitle=SCI TRANS MED：CRISPR-Cas9编辑造血干细胞，助力治疗相关移植, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=62aa1e679336)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365066, encodeId=d11c1365066b8, content=<a href='/topic/show?id=3f66412ebd' target=_blank style='color:#2F92EE;'>#Cas9#</a>, objectTitle=Biomaterials：通过Cas9/sgRNA编辑制备DNA适体免疫检查点, objectType=article, longId=176384, objectId=280d1e6384c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=280d1e6384c8, replyNumber=0, likeNumber=69, createdTime=2019-07-30, rootId=0, userName=respect, userId=8346212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=280d1e6384c8, moduleTitle=Biomaterials：通过Cas9/sgRNA编辑制备DNA适体免疫检查点, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=280d1e6384c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

Cas9

2020-05-29

respect (审核中...)

前往app查看评论内容

#Cas9#

当心！Nat Commun发文：CRISPR/Cas9基因编辑可能导致细胞毒性和基因组不稳定性

2022-08-28

respect (审核中...)

前往app查看评论内容

#Cas9#

JACS：中科大梁好均团队开发基于CRISPR-dCas9的可编程转录调节器

2022-07-09

respect (审核中...)

前往app查看评论内容

#Cas9#

现货型CAR-T疗法的危机：Cas9基因编辑后，T细胞繁现染色体异常

2022-07-08

respect (审核中...)

前往app查看评论内容

#Cas9#

Nature子刊：北京大学胡家志团队开发出更为安全的Cas9变体Cas9TX

2022-03-14

respect (审核中...)

前往app查看评论内容

#Cas9#

Cell Research：舒易来等开发CRISPR/Cas9-HMEJ基因修复体系治疗隐性遗传性聋

2022-03-02

respect (审核中...)

前往app查看评论内容

#Cas9#

NEJM：采用CRISPR-Cas9进行在体基因编辑治疗转甲状腺素蛋白淀粉样变性

2021-08-10

respect (审核中...)

前往app查看评论内容

#Cas9#

NEJM：CRISPR-Cas9体内基因编辑治疗转甲状腺素蛋白淀粉样变性

2021-08-07

respect (审核中...)

前往app查看评论内容

#Cas9#

N Engl J Med ：首次！CRISPR-Cas9技术可在人体实验中有效治疗镰状细胞贫血和β-地中海贫血

2021-01-01

respect (审核中...)

前往app查看评论内容

#Cas9#

CRISPR/ Cas9基因编辑疗法全新临床进展

2020-12-09

respect (审核中...)

前往app查看评论内容

#Cas9#

CELL：CRISPR/Cas9编辑人类胚胎可能导致大片段突变

2020-11-01

respect (审核中...)

前往app查看评论内容

#Cas9#

Br J Cancer：CRISPR/Cas9全基因组功能丧失筛选技术鉴定法尼基蛋白转移酶参与肾细胞癌的舒尼替尼耐药性

2020-10-07

respect (审核中...)

前往app查看评论内容

#Cas9#

Science：科学家发现新型基因编辑工具，体积是CRISPR-Cas9的一半

2020-07-24

respect (审核中...)

前往app查看评论内容

#Cas9#

CRISPR / Cas9疗法OTQ923治疗镰状细胞疾病：FDA已批准进行临床试验

2020-04-03

respect (审核中...)

前往app查看评论内容

#Cas9#

Circulation：CRISPR/Cas9基因编辑或可用于治疗LDLR突变型家族性高胆固醇血症

2020-01-06

respect (审核中...)

前往app查看评论内容

#Cas9#

PNAS：探究“致命”肺癌，科学家发现CRISPR-Cas9系统新应用

2020-01-01

respect (审核中...)

前往app查看评论内容

#Cas9#

Nat Commun：研究发现CRISPR-Cas9基因编辑系统在灵长类中不会导致明显的脱靶效应

2019-12-15

respect (审核中...)

前往app查看评论内容

#Cas9#

Vertex揭示了在首批接受CRISPR/Cas9基因编辑疗法患者中激动人心的数据

2019-11-25

respect (审核中...)

前往app查看评论内容

#Cas9#

Nat Biotech：媲美CRISPR-Cas9, 新CRISPR 工具探知90%的基因编辑领域

2019-09-30

respect (审核中...)

前往app查看评论内容

#Cas9#

SCI TRANS MED：CRISPR-Cas9编辑造血干细胞，助力治疗相关移植

2019-08-05

respect (审核中...)

前往app查看评论内容

#Cas9#

Biomaterials：通过Cas9/sgRNA编辑制备DNA适体免疫检查点

2019-07-30

科室
- - 订阅+
  - 更多科室
工具
服务